Page last updated: 2024-11-03

prazosin and Transposition of Great Vessels

prazosin has been researched along with Transposition of Great Vessels in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Transposition of Great Vessels: A congenital cardiovascular malformation in which the AORTA arises entirely from the RIGHT VENTRICLE, and the PULMONARY ARTERY arises from the LEFT VENTRICLE. Consequently, the pulmonary and the systemic circulations are parallel and not sequential, so that the venous return from the peripheral circulation is re-circulated by the right ventricle via aorta to the systemic circulation without being oxygenated in the lungs. This is a potentially lethal form of heart disease in newborns and infants.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dogan, R1
Dogan, OF1
Oc, M1
Duman, U1
Ozkutlu, S1
Celiker, A1

Other Studies

1 other study available for prazosin and Transposition of Great Vessels

ArticleYear
Noncompaction of ventricular myocardium in a patient with congenitally corrected transposition of the great arteries treated surgically: case report.
    The heart surgery forum, 2005, Volume: 8, Issue:2

    Topics: Adrenergic alpha-Antagonists; Echocardiography; Echocardiography, Doppler; Fatal Outcome; Female; He

2005